Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice

Endocrinology

Volumn 148, Issue 5, 2007, Pages 2075-2084

  Aoyagi, Toshinori ^a   Birumachi, Jun Ichi ^a   Hiroyama, Masami ^a   Fujiwara, Yoko ^a   Sanbe, Atsushi ^a   Yamauchi, Junji ^a   Tanoue, Akito ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ARGIPRESSIN; GLUCOSE; GLYCOGEN; VASOPRESSIN V1A RECEPTOR; INSULIN; LEPTIN; VASOPRESSIN RECEPTOR;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLYCOGEN LIVER LEVEL; HORMONE DEFICIENCY; HYPERINSULINEMIA; LIPID DIET; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; FAT INTAKE; FEEDING BEHAVIOR; GENETICS; HOMEOSTASIS; LIVER; MALE; METABOLIC SYNDROME X; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; PLASMA VOLUME;

ANIMALS; ARGININE VASOPRESSIN; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FATS; ENERGY INTAKE; FEEDING BEHAVIOR; GLYCOGEN; HOMEOSTASIS; INSULIN; LEPTIN; LIVER; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OBESITY; PLASMA VOLUME; RECEPTORS, VASOPRESSIN;

EID: 34249776085     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1315     Document Type: Article

References (52)

1. Morel A, O'Carroll AM, Brownstein MJ, Lolait SJ 1992 Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature 356:523-526
2. Lolait SJ, O'Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ 1992 Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336-339
3. Keyzer Y, Auzan C, Lenne F, Beldjord C, Thibonnier M, Bertagna X, Clauser E 1994 Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Lett 356:215-220
4. Hirasawa A, Hashimoto K, Tsujimoto G 1994 Distribution and developmental change of vasopressin V1a and V2 receptor mRNA in rats. Eur J Pharmacol 267:71-75
5. Jackson EK 1996 Vasopressin and other agents affecting the renal conservation of water. Hardman JG, Limbird LE, Gilman AG, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill; 715-731
6. Serradeil-Le Gal C, Herbert JM, Delisee C, Schaeffer P, Raufaste D, Garcia C, Dol F, Marty E, Maffrand JP, Le Fur G 1995 Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells. Am J Physiol 268:H404-H410
7. Inaba K, Umeda Y, Yamane Y, Urakami M, Inada M 1988 Characterization of human platelet vasopressin receptor and the relation between vasopressin-induced platelet aggregation and vasopressin binding to platelets. Clin Endocrinol (Oxf) 29:377-386
8. Kirk CJ, Rodrigues LM, Hems DA 1979 The influence of vasopressin and related peptides on glycogen phosphorylase activity and phosphatidylinositol metabolism in hepatocytes. Biochem J 178:493-496
9. Tanoue A, Ito S, Honda K, Oshikawa S, Kitagawa Y, Koshimizu TA, Mori T, Tsujimoto G 2004 The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J Clin Invest 113:302-309
10. Oshikawa S, Tanoue A, Koshimizu T, Kitagawa Y, Tsujimoto G 2004 Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach. Mol Pharmacol 65:623-629
11. Jard S, Gaillard RC, Guillon G, Marie J, Schoenenberg P, Muller AF, Manning M, Sawyer WH 1986 Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol 30:171-177
12. Thibonnier M, Coles P, Thibonnier A, Shoham M 2002 Molecular pharmacology and modeling of vasopressin receptors. Prog Brain Res 139:179-196
13. Thibonnier M 1988 Vasopressin and blood pressure. Kidney Int Suppl 25:S52-S56
14. Walsh CH, Baylis PH, Malins JM 1979 Plasma arginine vasopressin in diabetic ketoacidosis. Diabetologia 16:93-96
15. Zerbe RL, Vinicor F, Robertson GL 1979 Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 28:503-508
16. Milles JJ, Baylis PH, Wright AD 1981 Plasma vasopressin during insulin withdrawal in insulin-dependent diabetes. Diabetologia 20:607-611
17. Kamoi K, Ishibashi M, Yamaji T 1991 Thirst and plasma levels of vasopressin, angiotensin II and atrial natriuretic peptide in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Practice 11:195-202
18. Assimacopouls-Jeannet F, Cantau B, van de Werve G, Jard S, Jeanrenaud B 1983 Lack of vasopressin receptors in liver, but not in kidney, of ob/ob mice. Biochem J 216:475-480
19. Trinder D, Phillips PA, Stephenson JM, Risvanis J, Aminian A, Adam W, Cooper M, Jhonston CI 1994 Vasopressin V1 and V2 receptors in diabetes mellitus. Am J Physiol Endocrinol Metab 266:E217-E223
20. Hems DA, Ma GY 1976 Resistance to hepatic action of vasopressin in genetically obese (ob/ob) mice. Biochem J 160:23-28
21. McKenna K, Morris AD, Ryan M, Newton RW, Frier BM, Baylis PH, Saito T, Ishikawa S, Thompson CJ 2000 Renal resistance to vasopressin in poorly controlled type 1 diabetes mellitus. Am J Physiol Endocrinol Metab 279:E155-E160
22. Agha A, Smith D, Finucane F, Sherlock M, Morris A, Baylis P, Thompson CJ 2004 Attenuation of vasopressin-induced antidiuresis in poorly controlled type 2 diabetes. Am J Physiol Endocrinol Metab 287:E1100-E1106
23. Hiroyama M, Aoyagi T, Fujiwara Y, Birumachi J, Shigematsu Y, Kiwaki K, Tasaki R, Endo F, Tanoue A 2007 Hypermetabolism of fat in V1a vasopressin receptor knockout mice. Mol Endocrinol 21:247-258
24. Koshimizu T, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T, Takeo S, Okamura H, Tsujimoto G 2006 V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity. Proc Natl Acad Sci USA 103:7807-7812
25. Lang RE, Tholken H, Ganten G, Luft FC, Ruskoaho H, Unger T 1985 Atrial natriuretic factor - a circulating hormone stimulated by volume loading. Nature 314:264-266
26. Sengenes C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J 2000 Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 14:1345-1351
27. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS 2004 Impact of obesity on plasma natriuretic peptide levels. Circulation 109:594-600
28. Kim JK, Michel MD, Previs SF, Peroni OD, Mauvais-Jarvis F, Neschen S, Kahn BB, Kahn CR, Shulman GI 2000 Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest 105:1791-1797
29. Fisher SJ, Kahn CR 2003 Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. J Clin Invest 111:463-468
30. Okamoto H, Obici S, Accili D, Rossetti L 2005 Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest 115:1314-1322
31. Lust WD, Passonneau JV, Crites SK 1975 The measurement of glycogen in tissues by amylo-α-1,4-α-1,6-glucosidase after the destruction of preexisting glucose. Anal Biochem 68:328-331
32. Roesler WJ, Pugazhenthi S, Khandelwal RL 1990 Hepatic glycogen metabolism in the db/db mouse. Mol Cell Biochem 92:99-106
33. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephaene TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295
34. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS 1995 Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311-1314
35. Waldhausl W, Bratusch-Marrain P, Gasic S, Korn A, Nowotny P 1982 Insulin production rate, hepatic insulin retention, and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinemic type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 23:6-15
36. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 2003 Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26:S5-S20
37. Oomura Y, Ooyama H, Sugimori M, Nakamura T, Yamada Y 1974 Glucose inhibition of the glucose-sensitive neurons in the rat lateral hypothalamus. Nature 247:284-286
38. Scarpace PJ, Matheny M, Tumer N, Cheng KY, Zhang Y 2005 Leptin resistance exacerbates diet-induced obesity and is associated with diminished maximal leptin signaling capacity in rats. Diabetologia 48:1075-1083
39. Yun J, Schoneberg T, Liu J, Schulz A, Ecelbarger CA, Promeneur D, Nielsen S, Sheng H, Grinberg A, Deng C, Wess J 2000 Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene. J Clin Invest 106:1361-1371
40. 2-receptor-dependent regulation of AQP2 expression in Brattleboro rats. Am J Physiol Renal Physiol 279:F370-F382
41. Cho KW, Lee SJ, Wen JF, Kim SH, Seul KH, Lee HS 2002 Mechanical control of extracellular space in rabbit atria: an intimate modulator of the translocation of extracellular fluid and released atrial natriuretic peptide. Exp Physiol 87:185-194
42. Ostrowski NL, Lolite SJ, Young 3rd WS 1994 Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature. Endocrinology 135:1511-1528
43. Hermes MLHJ, Ruijter JM, Klop A, Buijs RM, Renaud LP 2000 Vasopressin increases GABAergic inhibition of rat hypothalamic paraventricular nucleus neurons in vitro. J Neurophysiol 83:705-711
44. Kalsbeek A, La Fleur S, Van Heijningen C, Bujis RM 2004 Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver. J Neurosci 24:7604-7613
45. Ghosh PM, Mikhailova M, Bedolla R, Kreisberg JI 2001 Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor. Am J Physiol Renal Physiol 280:F972-F979
46. Perraudin V, Delarue C, Lefebvre H, Do Rego JL, Vaudry H, Kuhn JM 2006 Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies. J Clin Endocrinol Metab 91:1566-1572
47. Waldhausl W, Kleinberger G, Korn A, Dudczak R, Bratusch-Marrain P, Nowotny P 1979 Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes 28:577-584
48. Bratusch-Marrain PR, DeFronzo RA 1983 Impairment of insulin-mediated glucose metabolism by hyperosmolality in man. Diabetes 32:1028-1034
49. Schliess F, von Dahl S, Haussinger D 2001 Insulin resistance induced by loop diuretics and hyperosmolarity in perfused rat liver. Biol Chem 382:1063-1069
50. Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A 1999 An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 274:10071-10078
51. Chen D, Fucini RV, Olson AL, Hemmings BA, Pessin JE 1999 Osmotic shock inhibits insulin signaling by maintaining Akt/protein kinase B in an inactive dephosphorylated state. Mol Cell Biol 19:4684-4694
52. Rasouli M, Kalantari KR 2005 Comparison of methods for calculating serum osmolality: multivariate linear regression analysis. Clin Chem Lab Med 43:635-640